The site of IGHS makes use of Cookies so that you can have the best user experience for all the functionalities, without collection of any personal info. By continuing you do accept our privacy policy.

Expanding successful business relationships in Middle-East

Consciously and in line with its expansion goals, Innov-Cell Therapeutics, a subsidiary of the IGHS Group, has been establishing proximity contacts with business groups consolidated in the Middle East. 
This constitutes a major opportunity to push Kelo.Cell brand’s positioning within geographies of a singular growth, in the pharmaceutical sector’s framework, to be added as another solid demonstration of recognition of the Portuguese group’s work on the global market.
The permanent challenge of establishing effective, long-lasting relationships between partners, in the continuity of transactions, is the DNA of a company that possesses a product like Kelo.Cell Biogel – clinically tested scar care formula, recommended by internationally renowned healthcare professionals.
Operations based on the ability to communicate, the quality and innovation of the product, in face of the outlined expansion project.